+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

From
From
From
From
From
Mesothelin-Targeted Immunotherapy Pipeline Review - Product Thumbnail Image

Mesothelin-Targeted Immunotherapy Pipeline Review

  • Report
  • November 2024
  • Global
From
From
From
PSMA - Targeted Therapy Pipeline Review - Product Thumbnail Image

PSMA - Targeted Therapy Pipeline Review

  • Report
  • November 2024
  • Global
From
c-Met-Targeted Antibody Therapy Pipeline Review - Product Thumbnail Image

c-Met-Targeted Antibody Therapy Pipeline Review

  • Report
  • November 2024
  • Global
From
From
From
CD40 Agonists & CD40/L Antagonists Pipeline Review - Product Thumbnail Image

CD40 Agonists & CD40/L Antagonists Pipeline Review

  • Report
  • November 2024
  • Global
From
From
Aflibercept (Eylea) Biosimilars Pipeline Review - Product Thumbnail Image

Aflibercept (Eylea) Biosimilars Pipeline Review

  • Report
  • November 2024
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more